Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
Title
Type
[
Year
]
Filters:
Author
is
Papayannidis, Cristina
[Clear All Filters]
2015
Martinelli G
,
Oehler VG
,
Papayannidis C
,
Courtney R
,
M Shaik N
,
Zhang X
,
O'Connell A
,
McLachlan KR
,
Zheng X
,
Radich J
, et al.
Treatment with PF-04449913, an oral smoothened antagonist, in patients with myeloid malignancies: a phase 1 safety and pharmacokinetics study.
Lancet Haematol. 2015;2(8):e339-46.
PubMed
Google Scholar
2020
Marconi G
,
Talami A
,
Abbenante MChiara
,
Sartor C
,
Parisi S
,
Nanni J
,
Bertamini L
,
Ragaini S
,
Olivi M
,
de Polo S
, et al.
Mec (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplantat in acute myeloid leukemia.
Eur J Haematol. 2020.
PubMed
Google Scholar
Candoni A
,
Lazzarotto D
,
Ferrara F
,
Curti A
,
Lussana F
,
Papayannidis C
,
Del Principe MIlaria
,
Bonifacio M
,
Mosna F
,
Delia M
, et al.
Nelarabine as salvage therapy and bridge to allogeneic stem cell transplant in 118 adult patients with relapsed/refractory t-cell acute lymphoblastic leukemia/lymphoma. the campus-all study.
Am J Hematol. 2020.
PubMed
Google Scholar
Marconi G
,
de Polo S
,
Martinelli G
,
Nanni J
,
Bertamini L
,
Talami A
,
Olivi M
,
Ragaini S
,
Abbenante MChiara
,
Sartor C
, et al.
Safety profile and impact on survival of tyrosine kinase inhibitors versus conventional therapy in relapse or refractory FLT3 positive acute myeloid leukemia patients.
Leuk Res. 2020;101:106497.
PubMed
Google Scholar
2021
Cristiano G
,
Nanni J
,
Sartor C
,
Parisi S
,
Marconi G
,
Barbato F
,
Arpinati M
,
Bonifazi F
,
Curti A
,
Cavo M
, et al.
Clinical Efficacy of Ponatinib in Philadelphia-Positive T-Cell Acute Lymphoblastic Leukemia with Extramedullary Involvement.
Acta Haematol. 2021:1-5.
PubMed
Google Scholar
Martinelli G
,
Papayannidis C
,
Piciocchi A
,
Robustelli V
,
Soverini S
,
Terragna C
,
Marconi G
,
Lemoli RMassimo
,
Guolo F
,
Fornaro A
, et al.
INCB84344-201: Ponatinib and steroids in frontline therapy of unfit patients with Ph+ acute lymphoblastic leukemia.
Blood Adv. 2021.
PubMed
Google Scholar
2023
Malfona F
,
Tanasi I
,
Piccini M
,
Papayannidis C
,
Federico V
,
Mancini V
,
Roncoroni E
,
Todisco E
,
Bianchi S
,
Ciotti G
, et al.
BH3 mimetics in relapsed and refractory adult acute lymphoblastic leukemia: a Campus ALL real-life study.
Haematologica. 2023.
PubMed
Google Scholar
Ravandi F
,
Döhner H
,
Wei AH
,
Montesinos P
,
Pfeilstöcker M
,
Papayannidis C
,
Lai Y
,
Wang K
,
See WL
,
de Menezes DLopes
, et al.
Survival outcomes in patients with acute myeloid leukaemia who received subsequent therapy for relapse in QUAZAR AML-001.
Br J Haematol. 2023.
PubMed
Google Scholar